2020 Good Quality Doxycycline Mono Uses - Bictegravir 1611493-60-7 – CPF
2020 Good Quality Doxycycline Mono Uses - Bictegravir 1611493-60-7 – CPF Detail:
Description
Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM.
In Vitro
Bictegravir (BIC) inhibits the strand transfer activity with an IC50 of 7.5± 0.3 nM. Relative to its inhibition of strand transfer activity, Bictegravir is a much weaker inhibitor of 3′-processing activity of HIV-1 IN, with an IC50 of 241±51 nM. Bictegravir enhances the accumulation of 2-LTR circles ~5-fold relative to the mock-treated control and reduces the amount of authentic integration products in infected cells by 100-fold. Bictegravir potently inhibits HIV-1 replication in both MT-2 and MT-4 cells with EC50s of 1.5 and 2.4 nM, respectively. Bictegravir exhibits potent antiviral effects in both primary CD4+ T lymphocytes and monocyte-derived macrophages, with EC50s of 1.5±0.3 nM and 6.6±4.1 nM, respectively, which are comparable to values obtained in T-cell lines[1].
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date |
Phase |
NCT03998176 | University of Nebraska|Gilead Sciences | HIV-1-infection | October 9, 2019 |
Phase 4 |
NCT03789968 | Thomas Jefferson University|University of Maryland, College Park|Indiana University Health|The Brooklyn Hospital Center|University of Illinois at Chicago|Nova Southeastern University|University of California, San Francisco | HIV+AIDS | September 1, 2019 | |
NCT04249037 | University of Colorado, Denver|Gilead Sciences | HIV+AIDS | March 1, 2020 |
Not Applicable |
NCT04132674 | Vancouver Infectious Diseases Centre | Human Immunodeficiency Virus I Infection|Drug Use | November 26, 2018 |
Phase 4 |
NCT04054089 | Cristina Mussini|University of Modena and Reggio Emilia | HIV Infections | September 2019 |
Phase 4 |
NCT04155554 | Azienda Ospedaliera Universitaria Senese|Catholic University of the Sacred Heart|Ospedale Policlinico San Martino|Azienda Ospedaliera San Paolo|Ospedale Amedeo di Savoia | HIV-1-infection | January 29, 2020 |
Phase 3 |
NCT02275065 | Gilead Sciences | HIV-1 Infection | October 2014 |
Phase 1 |
NCT03711253 | University of Southern California | Acute HIV Infection | October 14, 2019 |
Phase 4 |
NCT02400307 | Gilead Sciences | HIV | April 17, 2015 |
Phase 1 |
NCT03499483 | Fenway Community Health | HIV Prevention | January 24, 2019 |
Phase 4 |
NCT03502005 | Midland Research Group, Inc.|Gilead Sciences | Human Immunodeficiency Virus | March 1, 2018 |
Phase 4 |
Chemical structure
Proposal 18 Quality Consistency Evaluation projects which have approved 4, and 6 projects are under approving.
Advanced international quality management system has laid solid foundation for sales.
Quality supervision runs through the whole life cycle of the product to ensure the quality and therapeutic effect.
Professional Regulatory Affairs team supports the quality demands during the application and registration.
VIEW MORE
VIEW MORE
International cooperation
Domestic cooperation
Product detail pictures:
Related Product Guide:
With sophisticated technologies and facilities, strict top quality handle, reasonable value, exceptional support and close co-operation with clients, we are devoted to furnishing the ideal worth for our clients for 2020 Good Quality Doxycycline Mono Uses - Bictegravir 1611493-60-7 – CPF , The product will supply to all over the world, such as: Lebanon, Victoria, Ethiopia, Most problems between suppliers and clients are due to poor communication. Culturally, suppliers can be reluctant to question items they do not understand. We break down people barriers to ensure you get what you want to the level you expect, when you want it. Faster delivery time and the product you want is our Criterion .
By Constance from Miami - 2018.05.13 17:00
The company can think what our think, the urgency of urgency to act in the interests of our position, can be said this is a responsible company, we had a happy cooperation!
By Andrew from Cape Town - 2018.12.11 11:26